Ramon Güimil García
Directeur Technique/Scientifique/R&D chez Hummingbird Diagnostics GmbH
Postes actifs de Ramon Güimil García
Sociétés | Poste | Début | Fin |
---|---|---|---|
Hummingbird Diagnostics GmbH
Hummingbird Diagnostics GmbH Medical SpecialtiesHealth Technology Hummingbird Diagnostics GmbH specializes in patient-friendly diagnostics for early disease detection, personalized medicine, and lifetime health monitoring. Hummingbird Diagnostics is based in Heidelberg, DE and was founded by Jochen Kohlhaas and Karoly Nikolich. The German company uses liquid biopsies based on miRNA biomarkers to detect diseases such as lung cancer, melanoma, breast cancer, multiple sclerosis, Alzheimer's, Parkinson's, heart diseases, and IBD. Jochen Kohlhaas has been the CEO since incorporation. | Directeur Technique/Scientifique/R&D | 30/11/2009 | - |
Historique de carrière de Ramon Güimil García
Anciens postes connus de Ramon Güimil García
Sociétés | Poste | Début | Fin |
---|---|---|---|
The European Molecular Biology Laboratory | Corporate Officer/Principal | 01/01/1995 | - |
Nucleic Acid Synthesis Group | Corporate Officer/Principal | 01/01/1990 | - |
Statistiques
Internationale
Allemagne | 4 |
Opérationnelle
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Sectorielle
Health Technology | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
Hummingbird Diagnostics GmbH
Hummingbird Diagnostics GmbH Medical SpecialtiesHealth Technology Hummingbird Diagnostics GmbH specializes in patient-friendly diagnostics for early disease detection, personalized medicine, and lifetime health monitoring. Hummingbird Diagnostics is based in Heidelberg, DE and was founded by Jochen Kohlhaas and Karoly Nikolich. The German company uses liquid biopsies based on miRNA biomarkers to detect diseases such as lung cancer, melanoma, breast cancer, multiple sclerosis, Alzheimer's, Parkinson's, heart diseases, and IBD. Jochen Kohlhaas has been the CEO since incorporation. | Health Technology |
Nucleic Acid Synthesis Group |
- Bourse
- Insiders
- Ramon Güimil García
- Expérience